5/10
04:44 am
vrtx
OrthoXel's Vertex Hip Fracture Nail system obtains US clearance [Yahoo! Finance]
Low
Report
OrthoXel's Vertex Hip Fracture Nail system obtains US clearance [Yahoo! Finance]
5/9
04:44 pm
vrtx
Alpine Immune Sciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Alpine Immune Sciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/9
09:29 am
vrtx
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]
Low
Report
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]
5/9
08:33 am
vrtx
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN) [Yahoo! Finance]
Low
Report
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN) [Yahoo! Finance]
5/8
11:24 am
vrtx
Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Low
Report
Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
5/8
07:08 am
vrtx
Editas Medicine GAAP EPS of -$0.76 misses by $0.18, revenue of $1.14M misses by $6.16M [Seeking Alpha]
Low
Report
Editas Medicine GAAP EPS of -$0.76 misses by $0.18, revenue of $1.14M misses by $6.16M [Seeking Alpha]
5/7
11:33 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/7
11:08 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Royal Bank of Canada from $417.00 to $424.00. They now have a "sector perform" rating on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Royal Bank of Canada from $417.00 to $424.00. They now have a "sector perform" rating on the stock.
5/7
08:01 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Piper Sandler from $450.00 to $456.00. They now have an "overweight" rating on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Piper Sandler from $450.00 to $456.00. They now have an "overweight" rating on the stock.
5/7
08:01 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
5/7
08:01 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $462.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $462.00 price target on the stock.
5/6
11:03 pm
vrtx
Dow Jones Up As Disney Stock Jumps; Elon Musk Tells Warren Buffett To Buy This Stock [Yahoo! Finance]
Low
Report
Dow Jones Up As Disney Stock Jumps; Elon Musk Tells Warren Buffett To Buy This Stock [Yahoo! Finance]
5/6
09:03 pm
vrtx
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/6
06:44 pm
vrtx
UPDATE 1-Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments [Yahoo! Finance]
Low
Report
UPDATE 1-Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments [Yahoo! Finance]
5/6
04:13 pm
vrtx
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments [Reuters]
Low
Report
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments [Reuters]
5/6
04:10 pm
vrtx
Vertex Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Vertex Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/6
04:01 pm
vrtx
Vertex Reports First Quarter 2024 Financial Results
Low
Report
Vertex Reports First Quarter 2024 Financial Results
5/3
11:32 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
5/2
07:52 pm
vrtx
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know [Yahoo! Finance]
5/1
10:26 am
vrtx
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
4/30
09:23 am
vrtx
American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day [Yahoo! Finance]
Low
Report
American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day [Yahoo! Finance]
4/29
11:54 am
vrtx
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]
4/28
08:54 am
vrtx
2 Top Growth Stocks to Buy Right Now and Hold Forever [Yahoo! Finance]
Low
Report
2 Top Growth Stocks to Buy Right Now and Hold Forever [Yahoo! Finance]
4/26
01:20 pm
vrtx
Pioneer Institute study finds IRA discourages non-opioid drug innovation [Yahoo! Finance]
Low
Report
Pioneer Institute study finds IRA discourages non-opioid drug innovation [Yahoo! Finance]
4/26
11:55 am
vrtx
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older [Yahoo! Finance]
Low
Report
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older [Yahoo! Finance]